
|Articles|August 10, 2020
Efficacy and safety of intravitreal aflibercept (Eylea®) therapy using a proactive treat-and-extend regimen in neovascular AMD
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Tenpoint Therapeutics opens telehealth access to Yuvezzi for adults with presbyopia
2
The interplay between cardiac disease and the eye
3
City Therapeutics doses first participant in phase 1 trial of RNAi therapy CITY-RBP4 for Stargardt disease
4
Longer anti-VEGF intervals in AMD, BRVO, and DME: 3 clinical cases
5















